Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

10:45 AM - 10:55 AM ET

177 - "No Phase III? No Worries!": Analysis of over 1100 Inoperable Early-Stage Lung Cancer Patients Treated with Either Single- or Three-Fraction SBRT to Reveal a Standard of Care
Speaker: Videtic, Gregory, MD, CM, FRCPC, FACR, FASTRO - Cleveland Clinic, Cleveland Heights, OH
10:45 AM - 10:55 AM ET

183 - Radiosurgical Capsulotomy, a Novel Approach for Treatment-Resistant Major Depression: A Prospective Observational Study
Speaker: Khattab, Mohamed, MD - University of South Florida, Tampa, FL
10:45 AM - 10:55 AM ET

190 - Clinical Utility of a Brief Validated Patient-Reported Quality-of-Life (QoL) Tool in Routine Oncology Care: Results of a Randomized Controlled Trial
Speaker: Krishnamurthy, Revathy, MD - Tata Memorial Centre, Mumbai, Mumbai, Maharashtr
10:45 AM - 10:55 AM ET

197 - Super Resolution Ionizing Radiation Acoustic Beam Localization during Proton Beam Therapy
Speaker: Zhang, Wei, PhD - University of Michigan, Ann Arbor, MI
10:45 AM - 10:55 AM ET

203 - Clinical Factors Associated with Response to Low-Dose Total Skin Electron Beam Therapy: A Multi-Institutional Study By ILROG
Speaker: Chiang, Jennifer, MD, MS - Stanford Health Care, Stanford, CA
10:45 AM - 12:00 PM ET

Immunotherapy Integration and Immuno Biomarkers Across Mucosal and Cutaneous SCC
Speaker: Bratman, Scott, MD, PhD - Princess Margaret Cancer Centre, University of Toronto, Toronto, ON
10:45 AM - 12:00 PM ET

Immunotherapy Integration and Immuno Biomarkers Across Mucosal and Cutaneous SCC
Speaker: Young, Melissa, MD, PhD - Yale University, New Haven, CT
10:55 AM - 11:05 AM ET

166 - FAPI-Guided Radiotherapy + Cadonilimab with Systemic Therapy vs. Systemic Therapy Alone in Second-Line Treatment of Colorectal Peritoneal Metastasis (TORCH-PM01)
Speaker: Zhang, Zhiyuan, MD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
10:55 AM - 11:05 AM ET

173 - C-Post Study of Adjuvant Cemiplimab for High-Risk Cutaneous Squamous Cell Carcinoma: Impact of Adjuvant Radiotherapy on Disease-Free Survival
Speaker: Adams, Gerard, MB, ChB, FRANZCR - Genesis Care Bundaberg, Bundaberg, QLD
10:55 AM - 11:05 AM ET

178 - A Dose Escalation Study of Papaverine As a Selective Hypoxic Radiosensitizer for Lung Stereotactic Body Radiation Therapy (SBRT) In the Treatment of Early-Stage Non-Small Cell Lung Cancer (NSCLC) and Other Malignancies
Speaker: Brownstein, Jeremy, MD, MS - Ohio State University James Cancer Hospital, Columbus, OH
10:55 AM - 11:05 AM ET

184 - A Randomized Controlled Trial of Dose Evaluation in Single-Fraction Electron Beam Radiotherapy for Keloids
Speaker: Kuo, Deng-Yu, MD, MPH - Department of Biomedical Engineering, National Yang Ming Chiao Tung University, Taipei, Taiwan
10:55 AM - 11:05 AM ET

191 - Germline Genetic Risk Factors are Associated with Cardiac Dysfunction among Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study (CCSS) and St. Jude Lifetime Cohort Study (SJLIFE)
Speaker: Kerns, Sarah, PhD, MPH - Medical College of Wisconsin, Milwaukee, Wisconsin